Further investigation should be performed to assess whether the low TYK2 expression found in ALL-blasts could favour the survival of leukaemic blasts in response to apoptotic signals and to define the role of these changes in B cell leukaemic disease. Here, TYK2 is linked to acute lymphoblastic leukemia.